lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer

Figure 3

Subgroup survival analysis. Survival analysis of clinical subgroups, including (a) stage I subgroup, (b) stage II subgroup, (c) stage III subgroup, (d) stage IV subgroup, (e) young subgroup, (f) old subgroup, (g) female subgroup, and (h) male subgroup.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)